# "Corticoid-16" in Long Term When Administered Systemically in Patients in Routine Medical Practice

> **NCT03119454** · — · COMPLETED · sponsor: **Federal State Budgetary Scientific Institution, Scientific Research Institute of Rheumatology** · enrollment: 40 (actual)

## Conditions studied

- Pharmacological Action

## Interventions

- **DRUG:** Diprospan

## Key facts

- **NCT ID:** NCT03119454
- **Lead sponsor:** Federal State Budgetary Scientific Institution, Scientific Research Institute of Rheumatology
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-10
- **Primary completion:** 2016-11
- **Final completion:** 2016-12
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2017-04-18

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03119454

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03119454, ""Corticoid-16" in Long Term When Administered Systemically in Patients in Routine Medical Practice". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03119454. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*